D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment
- 1 March 1992
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 575 (1) , 47-56
- https://doi.org/10.1016/0006-8993(92)90421-5
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptorsJournal of Neuroscience, 1988
- Selective D1and D2Receptor Manipulation in Cebus Monkeys: Relevance for Dystonia and Dyskinesia in HumansBasic & Clinical Pharmacology & Toxicology, 1987
- Dopamine receptor subtype imbalance in schizophreniaLife Sciences, 1987
- Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatumEuropean Journal of Pharmacology, 1986
- Differential Effect of Subchronic Treatment with Various Neuroleptic Agents on Serotonin2 Receptors in Rat Cerebral CortexJournal of Neurochemistry, 1986
- 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brainEuropean Journal of Pharmacology, 1984
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six monthsNature, 1979
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976